Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06096714 · ClinicalTrials.gov registry record · Early Phase 1
Addictive Threshold of Nicotine
A Early Phase 1 study of Smoking Addiction, sponsored by Yale University.
- Recruiting
- Registry status
- Early Phase 1
- Development phase
- 36
- Enrollment target
- 1
- Study location
NCT06096714 is a Early Phase 1 study of Smoking Addiction that is actively recruiting participants, run by Yale University. The registered enrollment target is 36 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06096714, a Early Phase 1 study of Smoking Addiction, is actively recruiting participants, sponsored by Yale University.
- RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 36 participants
- Enrollment target
- 1
- Study location
Study Summary
To determine the nicotine threshold dose(s) for discrimination, subjective-rewarding effects, -and reinforcement in smokers with different levels of dependence.
Conditions Studied
Interventions
- OTHER Saline
- DRUG Nicotine
Study Locations (1)
Connecticut
- VA Healthcare System - West Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2024-02-27 |
| Est. Completion | 2027-01-30 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06096714
The ClinicalTrials.gov registry entry for NCT06096714 describes a study currently listed as recruiting, categorized as Early Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Smoking Addiction appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.
NCT06096714 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT06096714 about?
NCT06096714 is a clinical study titled "Addictive Threshold of Nicotine". To determine the nicotine threshold dose(s) for discrimination, subjective-rewarding effects, -and reinforcement in smokers with different levels of dependence.
What is the current status of trial NCT06096714?
This trial is currently recruiting. It is a Early Phase 1 study. The enrollment target is 36 participants. The study started on 2024-02-27. Estimated completion is 2027-01-30.
What conditions does trial NCT06096714 study?
This clinical trial studies the following conditions: Smoking Addiction.
What interventions are being tested in trial NCT06096714?
The interventions under investigation include: Saline (OTHER), Nicotine (DRUG).
Who is sponsoring clinical trial NCT06096714?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06096714 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.